Strengthening management of sickle cell disease in Bangui
— The Central African Republic —
BACKGROUND
In 2011, pursuing the work already begun in Mali, Fondation Pierre Fabre became involved in the battle against sickle cell disease in the CAR. This country has a record rate of this illness, affecting 2% of infants, but also has very poor overall state of affairs in human health: the life expectancy, just 45 years, is ten years below the African average.
The Foundation focused its attention on the Bangui paediatric complex, an establishment created in 1988 providing care to those ages 0 to18 and the country’s sole modern paediatric healthcare facility. With the Foundation’s support, it would receive new equipment and supplies to improve patient reception, provide staff with increased knowledge of sickle cell disease (through cross-training with Bamako and Kinshasa), set up screening campaigns and raise public awareness of the disease.
KEY FACTS
_____
Priority
Combating Sickle cell disease
Programme
Since 2011
Type of involvement
Distributor and operator
Actions
- Supply of medical equipment and consumables
- Training funding and organisation
Perspectives
Unfortunately, in 2013, when the Foundation had already provided the planned materials and completed its contribution to healthcare worker training, civil war broke out. The humanitarian emergency gradually took precedence over the targeted programmes and the Foundation had to accept the necessity of suspending its interventions there. It hopes to resume activities as soon as possible.
PARTENAIRES
- Complexe pédiatrique de Bangui
See also
Support for the Sickle Cell Research and Treatment Centre (CRTD)
The Fondation Pierre Fabre has been supporting the Bangui Sickle Cell Research and Treatment Centre (CRTD) since 2019. The CRTD is the country’s only referral institution and receives financial support for training and purchasing medicines and equipment.
19/10/2021See also
Supporting the fight against sickle cell disease in Sub-Saharan Africa
This multi-country project must address the major challenge of reducing morbidity and mortality linked to sickle cell disease by acting on several levels: Detect, treat, train, raise awareness and support public authorities
30/03/2022Follow our actions
Pierre Fabre Fondation 2023 Annual Report
The Fondation Pierre Fabre is heir to the humanistic values and tireless commitment of its founder, Pierre Fabre, who instructed that it should participate “humbly but effectively in improving access to healthcare for the most disadvantaged populations, a key factor in a country’s development”. The Foundation’s status and the way it operates are valuable assets that help it stay true to its defence of the world’s least privileged communities. That commitment manifests itself in the form of an operational strategy based on three key areas of support: training, caring and innovating.